ARCHIVES

NIH Considering Intramural NRSA, NCI Advisors Not Enthusiastic

This article is from The Cancer Letter archive.

Vol. 10 No. 07 | February 17, 1984

Download PDF Visit The Full Archive

Related Articles

Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds.

December 14, 2001

Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity

January 30, 2009

NCAB Ok’s Funding First Three Years Of Diet Trial

December 7, 1990

Insurers Increasingly Willing To Cover ABMT For Breast Cancer, GAO Finds

June 7, 1996

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

NCI To Place 20% Cap On Grant Renewal Increases.

May 25, 2001